ETF · iShares · IBB
iShares Biotechnology ETF
iShares Biotechnology ETF (IBB) is an ETF from iShares that tracks the NYSE Biotechnology Index index. Its ongoing charge is 0.44% a year and it holds $10.7bn in assets. The fund uses physical replication, is distributing, is domiciled in United States.
IBB in figures
- Assets
- $10.7bn
- Ongoing charge (TER)
- 0.44%
- Holdings
- 243
- Weight of the ten largest
- 52.1%
- Dividend yield
- 0.4%
- Return, year to date (USD)
- +26.0%
- Return, 1 year (USD)
- +30.4%
- Return, 3 years a year (USD)
- +22.0%
- Return, 5 years a year (USD)
- +6.9%
- Volatility, 3 years (USD)
- 21.6%
Figures as of 13 November 2026. Past performance does not predict future returns. Information only, not investment advice.
Fund facts
- Issuer
- iShares
- Index
- NYSE Biotechnology Index
- Asset class
- Equity, Sector
- Region
- US
- Replication
- Physical
- Income
- distributing
- Domicile
- United States
- Currency hedged
- No
- Launched
- 5 February 2001
- ISIN
- US4642875565
Largest holdings
| GILEAD SCIENCES | 9.1% |
| AMGEN INC | 8.5% |
| VERTEX PHARMACEUTICALS | 7.9% |
| REGENERON PHARMACEUTICALS | 6.3% |
| MODERNA | 6.2% |
| ARGENX SE ADR | 3.5% |
| NATERA | 3.4% |
| BIOGEN | 2.5% |
| REVOLUTION MEDICINES | 2.4% |
| BEONE MEDICINES AG | 2.3% |
Sectors
| Biotechnology | 87.5% |
| Life Sciences Tools & Services | 9.6% |
| Pharmaceuticals | 2.7% |
| Health Care Services | 0.1% |
| Cash and/or Derivatives | 0.1% |
| Health Care Equipment | 0.1% |
Countries
| United States | 94.4% |
| Denmark | 2.1% |
| United Kingdom | 1.5% |
| Canada | 0.5% |
| France | 0.4% |
| Switzerland | 0.3% |
| Netherlands | 0.3% |
| China | 0.1% |
| Spain | 0.1% |
| Ireland | 0.1% |